Selective MEK Inhibition with AZD-6244 (selumetinib) in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL): A University of Chicago Phase II Consortium Trial
| Autor: | Galanina, Natalie, Smith, Sonali M., Liao, Chuanhong *, Petrich, Adam M., Libao, Bernadette *, Gartenhaus, Ron, Westin, Jason R, Cohen, Kenneth S., Knost, James *, Stadler, Walter, Doyle, Austin *, Karrison, Theodore *, Gordon, Leo I., Evens, Andrew M |
|---|---|
| Zdroj: | In Blood 3 December 2015 126(23):3990-3990 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|